None of the animals were sacrificed for this study
Metabolic characterization of imatinib-resistant BCR-ABL T315I chronic myeloid leukemia cells indicates down-regulation of glycolytic pathway and low ROS production
Its chemical stability and non-toxic copper delivery capacity further underscore its utility as a molecular tool for investigating gene expression, tissue regeneration, and copper-mediated biochemical processes (Pickart, Vasquez-Soltero, and Margolina 2012)
Most adverse events were gastrointestinal, such as nausea, diarrhea, or constipation, and occurred in 79.6% of the combination arm versus 39.9% of placebo recipients
| | Aggressive Stack | 12.515mg weekly (therapeutic dose) | 100mg daily | Weekly + daily | Maximal incretin effect + maximal NNMT inhibition | 1624 weeks | Highest theoretical synergy but also highest metabolic stress
Generally, TGF- inhibits preadipocyte differentiation in vitro by interacting with C/EBP and repressing its transcriptional activity